/CPMV
CPMV Stock - Mosaic ImmunoEngineering Inc.
Healthcare|BiotechnologyOTC
$0.50+52.29%
+$0.17 (+52.29%) • Dec 19
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CPMV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.49 – $0.50
TARGET (TP)$0.57
STOP LOSS$0.46
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.83
52W High$1.05
52W Low$0.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2019 | FY2017 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-879,655 | $-2,627,522 | $-3,661,278 | $-734,062 | $-1,047,127 |
| Net Income | $-921,983 | $-2,380,870 | $-3,684,478 | $-798,463 | $-1,209,450 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.13 | $-0.33 | $-0.55 | $-1.00 | $-1.52 |
Company Overview
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CPMVBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.02
Q4 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | — | $-0.02 | — | — |
Q3 2025 | Aug 19, 2025 | — | $-0.02 | — | — |
Q2 2025 | May 20, 2025 | — | $-0.03 | — | — |
Q4 2024 | Nov 19, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.04 | — | — |
Q2 2024 | Apr 15, 2024 | — | $-0.04 | — | — |
Q4 2023 | Nov 2, 2023 | — | $-0.05 | — | — |
Q3 2023 | Aug 3, 2023 | — | $0.00 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.06 | — | — |
Q1 2023 | Mar 2, 2023 | — | $-0.07 | — | — |
Q4 2022 | Nov 1, 2022 | — | $-0.02 | — | — |
Q3 2022 | Aug 4, 2022 | — | $-0.13 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.11 | — | — |
Q1 2022 | Jan 25, 2022 | — | $-0.12 | — | — |
Q4 2021 | Nov 2, 2021 | — | $-0.15 | — | — |
Q3 2021 | Aug 3, 2021 | — | $-0.14 | — | — |
Q2 2021 | May 5, 2021 | — | $-0.15 | — | — |
Q4 2020 | Dec 29, 2020 | — | $-0.79 | — | — |
Q4 2020 | Oct 15, 2020 | — | $-0.15 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CPMV
What is CPMV's current stock price?
Mosaic ImmunoEngineering Inc. (CPMV) is currently trading at $0.50 per share. The stock has moved +52.29% today.
What is the analyst price target for CPMV?
No analyst price targets are currently available for this stock.
What sector is Mosaic ImmunoEngineering Inc. in?
Mosaic ImmunoEngineering Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.
What is CPMV's market cap?
Mosaic ImmunoEngineering Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CPMV pay dividends?
No, Mosaic ImmunoEngineering Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBETRF
BetterLife Pharma Inc.
$0.04
Mkt Cap: $0.0B
BIXT
Bioxytran, Inc.
$0.07
Mkt Cap: $0.0B
BZYR
Burzynski Research Institute, Inc.
$0.04
Mkt Cap: $0.0B
CUBT
Curative Biotechnology, Inc.
$0.01
Mkt Cap: $0.0B
GLWLF
Glow Lifetech Corp.
$0.04
Mkt Cap: $0.0B
NSHSF
NanoSphere Health Sciences Inc.
$0.01
Mkt Cap: $0.0B
PHRRF
PharmaTher Holdings Ltd.
$0.08
Mkt Cap: $0.0B
QNNTF
Quantum Genomics S.A.
$0.10
Mkt Cap: $0.0B
THER
Theralink Technologies, Inc.
$0.00
Mkt Cap: $0.0B
TXTM
ProText Mobility, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to CPMV for comparison